PFKFB3 and inflammatory bowel disease: In summary, we found that PFKFB3 is highly expressed in stromal cells in IBD and that inhibition of PFKFB3 reduces inflammatory cytokine secretion by fibroblasts in vitro and attenuates in vivo experimental models of colitis.